In this Viewpoint article, five leading immunologists discuss the processes involved in the resolution of inflammation. Could drugs that promote pro-resolution pathways be more effective than drugs that block pro-inflammatory mediators in treating certain chronic inflammatory diseases? The contributors debate this and other key issues in the field.
- Christopher D. Buckley
- Derek W. Gilroy
- Paul P. Tak
